AiCuris

Merck's new CMV med Prevymis set for launch at $19K-plus

Merck's antiviral business suffered some serious blows this year, but it now boasts a new product: Prevymis, a CMV fighter approved by the FDA on Thursday.

Tracy Staton Nov 9, 2017 11:09am